alendronate has been researched along with Parodontosis in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocha, ML | 1 |
| Malacara, JM | 1 |
| Sánchez-Marin, FJ | 1 |
| Vazquez de la Torre, CJ | 1 |
| Fajardo, ME | 1 |
| Yaffe, A | 1 |
| Iztkovich, M | 1 |
| Earon, Y | 1 |
| Alt, I | 1 |
| Lilov, R | 1 |
| Binderman, I | 1 |
| Shih, WJ | 1 |
| Quan, H | 1 |
| Ciancio, SG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Is Dietary Melatonin Supplementation a Viable Adjunctive Therapy for Chronic Periodontitis? A Preliminary Randomized Clinical Trial.[NCT03368430] | Phase 4 | 74 participants (Actual) | Interventional | 2016-07-04 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Parodontosis
| Article | Year |
|---|---|
Systemic medications: clinical significance in periodontics.
Topics: Alendronate; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroida | 2002 |
1 trial available for alendronate and Parodontosis
| Article | Year |
|---|---|
Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial.
Topics: Administration, Oral; Aged; Alendronate; Alveolar Bone Loss; Bone Density; Double-Blind Method; Fema | 2004 |
2 other studies available for alendronate and Parodontosis
| Article | Year |
|---|---|
Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats.
Topics: Administration, Topical; Alendronate; Alveolar Bone Loss; Alveolar Process; Animals; Bone Diseases; | 1997 |
Planning and analysis of repeated measures at key time-points in clinical trials sponsored by pharmaceutical companies.
Topics: Alendronate; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Data Collectio | 1999 |